Trading Window

September 26, 2026 The Manager, Listing Department BSE Limited The National Stock Exchange of India Ltd. Corporate Relationship Department, Exchange Plaza, Bandra Kurla Complex, Phiroze Jeejeebhoy Towers, Bandra (E), Mumbai - 400 051 Dalal Street, Mumbai - 400 001 NSE Symbol: PANACEABIO BSE Scrip Code: 531349 Sub: Intimation of closure of Trading Window Dear Sir/Madam, Pursuant to the Company’s Code of Conduct for Prevention of Insider Trading framed in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, we would like to inform that the trading window of the Company shall remain closed for all the Designated Persons (including their immediate relatives) of the Company from October 01, 2026 till completion of 48 hours from the announcement of the unaudited financial results of the Company for the quarter and half year ending September 30, 2026, to the Stock Exchanges. The date of meeting of the Board of Directors to approve the unaudited financial results of the Company for the quarter and half year ending September 30, 2026, shall be informed in due course. This is for your kind information and record please. Thanking you, Sincerely yours, for Panacea Biotec Limited Ankit Jain General Manager – Legal & Company Secretary Panacea Biotec Limited (CIN: L33117PB1984PLC022350) Regd. Office : Ambala Chandigarh Highway, Lalru – 140501, Punjab Correspondence/Corporate office : B-1 Extn./A-27, Mohan Co-op. Indl. Estate, Mathura Road, New Delhi - 110 044, India Ph.: 91-11-4167 9000, 4167 8000, Fax: 91-11-4167 9070 Email: companysec@panaceabiotec.com